Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cornea ; 34(7): 833-4, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26010941

ABSTRACT

PURPOSE: To report a case of conjunctival squamous cell carcinoma in a patient with psoriasis treated with tumor necrosis factor-alpha inhibitors. METHODS: Case report and review of the literature. RESULTS: A 44-year-old white woman presented to our hospital 1 year after developing a rapidly growing nodular lesion with papillomatous characteristics on the bulbar conjunctiva. The patient had a medical history of psoriasis since childhood and psoriatic arthritis since 2009. She had received several immunosuppressive medications such as leflunomide, adalimumab, methotrexate, and etanercept. The lesion appeared a few months after commencing treatment with etanercept and methotrexate. A histological examination revealed a squamous intraepithelial neoplasm of the conjunctiva that was negative for human papillomavirus infection. CONCLUSIONS: Several case reports have described squamous cell carcinoma in different parts of the body in patients taking tumor necrosis factor-alpha inhibitors. Squamous cell neoplasm of the ocular surface should be considered during differential diagnosis of new conjunctival lesions in such patients.


Subject(s)
Arthritis, Psoriatic/pathology , Carcinoma in Situ/pathology , Conjunctival Neoplasms/pathology , Immunologic Factors/therapeutic use , Interferon-alpha/therapeutic use , Psoriasis/pathology , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Administration, Topical , Adult , Carcinoma in Situ/drug therapy , Conjunctival Neoplasms/drug therapy , Female , Humans , Interferon alpha-2 , Recombinant Proteins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...